Clincosm LogoSign in Get a demo

hnscc

Showing 26 - 49 of 49
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HNSCC Trial in Aurora (Alpha Lipoic Acid)

Recruiting
  • HNSCC
  • Alpha Lipoic Acid
  • Aurora, Colorado
    Abigail E Berry
May 12, 2022

HNSCC, Head and Neck Tumors Trial in Seoul (BYL719, Poziotinib, Nintedanib)

Completed
  • HNSCC
  • Head and Neck Neoplasms
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 27, 2022

HNSCC Trial in Avignon, Rennes (Durvalumab)

Recruiting
  • HNSCC
  • Avignon, France
  • +1 more
Mar 10, 2022

HNSCC Trial in Lorient (Cetuximab, avelumab, Cisplatin)

Active, not recruiting
  • HNSCC
  • Lorient, France
    Centre Hospitalier Bretagne Sud
Mar 10, 2022

HNSCC Trial in Saint-Mandé (Cisplatin, radiotherapy)

Recruiting
  • HNSCC
  • Saint-Mandé, France
    Hôpital Bégin
Mar 10, 2022

HNSCC Trial in Tucson (Abemaciclib)

Recruiting
  • HNSCC
  • Tucson, Arizona
    University of Arizona
Mar 3, 2022

Melanoma, NSCLC, Hepatocellular Carcinoma Trial in Pittsburgh (Nivolumab or Pembrolizumab (dependent upon approved indication),

Recruiting
  • Melanoma
  • +7 more
  • Nivolumab or Pembrolizumab (dependent upon approved indication)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 10, 2022

HNSCC Trial in Houston (Bimiralisib)

Terminated
Has Results
  • HNSCC
  • Houston, Texas
    M.D. Anderson Cancer Center
Dec 22, 2021

Artificial Intelligence in Functional Imaging for Individualized

Recruiting
  • HNSCC
  • Observation
  • Berlin, Germany
    Department of Radiooncology and Radiotherapy, Charité - Universi
Jan 13, 2022

HPV-Related Squamous Cell Carcinoma, HNSCC Trial in Chicago (drug, procedure, radiation)

Active, not recruiting
  • HPV-Related Squamous Cell Carcinoma
  • HNSCC
  • Chicago, Illinois
    University of Chicago Medical Center
Nov 12, 2021

Tumors, Hiv, Cervical Cancer Trial in Gaborone (Potlako intervention, Enhanced care)

Recruiting
  • Neoplasms
  • +7 more
  • Potlako intervention
  • Enhanced care
  • Gaborone, Botswana
    Botswana Harvard AIDS Institute
Sep 21, 2021

Dose-Effect Relation of Salivary Gland Irradiation

Completed
  • HNSCC
  • PSMA PET/CT-scan
  • Amsterdam, Noord-Holland, Netherlands
  • +2 more
Aug 18, 2021

HNSCC, Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Tucson (Avmacol®)

Completed
  • HNSCC
  • +7 more
  • Tucson, Arizona
    The University of Arizona Cancer Center
Jun 17, 2021

Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and

Recruiting
  • HNSCC
  • +6 more
  • Conventional Therapy acc. to prevailing clincal approved schemes
  • Erlangen, Bavaria, Germany
    Department of Radiation Oncology, Universitätsklinikum Erlangen
May 18, 2021

HNSCC Trial in Beijing (Camrelizumab)

Not yet recruiting
  • HNSCC
  • Beijing, China
    Cancer hospital, Chineses Academy of Medical Sciences
Apr 25, 2021

HRAS Gene Mutation, HNSCC Trial in Worldwide (Tipifarnib, HRAS Detection Assay)

Recruiting
  • HRAS Gene Mutation
  • HNSCC
  • Los Angeles, California
  • +131 more
Feb 24, 2021

Organoids, HNSCC, Epithelial Ovarian Cancer Trial in Singapore (Tumor Core Biopsy, Blood sampling)

Unknown status
  • Organoids
  • +3 more
  • Tumor Core Biopsy
  • Blood sampling
  • Singapore, Singapore
    National University Hospital
Sep 8, 2020

HNSCC Trial in France (cetuximab, Carboplatin, 5FU concomitant, Radiotherapy)

Completed
  • HNSCC
  • Annecy, France
  • +4 more
Apr 14, 2020

WGA in Platinum-refractory HNSCC Underwent Nivolumab

Unknown status
  • HNSCC
  • HNSCC patients have used Nivolumab
  • Taoyuan, Taiwan
  • +1 more
Apr 24, 2019

HNSCC Trial in Seoul (HM781-36B)

Unknown status
  • HNSCC
  • Seoul, Korea, Republic of
    Yonsei University
Mar 14, 2019

Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer Trial in Houston (COTI2, Cisplatin)

Unknown status
  • Ovarian Cancer
  • +9 more
  • Houston, Texas
    MD Anderson Cancer Center
Jan 30, 2019

Nivolumab in Head and Neck Squamous Cell Carcinoma

Unknown status
  • HNSCC
  • +2 more
  • Athens, Chaidari, Greece
    Attikon Hospital
Aug 27, 2018

HNSCC, Head and Neck Tumors Trial in Seoul (Abemaciclib)

Unknown status
  • HNSCC
  • Head and Neck Neoplasms
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Nov 24, 2017

HNSCC Trial in Montpellier (Taxotere, Cisplatin, Afatinib)

Completed
  • HNSCC
  • Taxotere, Cisplatin, Afatinib
  • Montpellier, France
    ICM Val d'Aurelle, Montpellier
Oct 25, 2017